In March 2023, the DCM Foundation along with all major cardiomyopathy patient groups, and eight biopharma companies launched the Genetic Cardiomyopathy Awareness Campaign and Consortium (“GCAC”).
This campaign and the new “GCAC” website offer detailed information about:
- The important role of genetics and cardiomyopathy.
- The need for genetic testing.
- An easy and inexpensive path to get genetically tested.
Please click here to learn about genetic cardiomyopathy testing and counseling services.
Please visit www.geneticcardiomyopathy.org to learn more about genetic cardiomyopathy.
For more information about DCM Genetics please click here.